- YMAB Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Y-mAbs Therapeutics (YMAB) 8-K23 Jun 21Y-mAbs Provides Regulatory Update on Omburtamab for the Treatment of Patients with NeuroblastomaFinancial data
Company Profile